Mycoplasma arthritidis superantigen

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 72, 435 5, C07N 2104

Patent

active

057959749

ABSTRACT:
The gene encoding the superantigen Mycoplasma arthritidis T-cell mitogen (MAM) was molecularly cloned. The mam gene was modified by site-directed mutagenesis to change UGA codons, which in mycoplasmas are read as tryptophan codons instead of universal stop codons, to UGG codons such that the gene could be expressed in standard expression systems. Recombinant MAM, including extra amino acid residues at the N- and C-termini, were expressed and discovered to be biologically active. Certain amino acid substitutions in active regions of the protein also yield biologically active MAM proteins. A method of diagnosing rheumatoid arthritis using recombinant MAM protein in an ELISA assay is disclosed.

REFERENCES:
patent: 5639869 (1997-06-01), Cole et al.
Kevin L. Knudston et al., Expression of the Mycoplasma Arthritidis Mitogen Gene (mam) In Escherichia coli, 3 I.O.M. Letters Congress of Intl. Org. Mycoplasmology Jul. 19-26 609-610 (1994) (abstr.)
Barry C. Cole et al., Immunomodulation In Vivo by the Mycoplasma arthritidis Superantigen, MAM, 17 Clin. Inf. Dis. S163-S169 (supp. 1, 1993).
C. Gidolf et al., Antibodies are Capable of Directing Superantigen-mediated T Cell Killing of Chronic B Lymphocytic Leukemia Cells, 9 Leukemia 1534-42 (1995).
Dohlsten et al., Antibody-targeted Superantigens are Potent Inducers of Tumor-infiltrating T Lymphocytes in vivo, 92 Proc. Nat'l. Acad. Sci. USA 9791-9795 (1995).
Dohlsten at al., Monoclonal Antibody-superantigen Fusion Proteins: Tumor-specific Agents for T-cell-based Tumor Therapy, 91 Proc. Nat'1.Sci. USA 8945-8949 (1994).
Colin R.A. Hewitt et al., The Superantigenic Activities of Bacterial Toxins, Molecular Biology of Bacterial Infections 149-172 (1992).
Janice White et al., The V.beta.-Specific Superantigen Staphylococcal Enterotoxin B: Stimulation of Mature T Cells and Clonal Deletion in Neonatal Mice, 50 Cell 27-35 (1989).
Barry C. Cole et al., Stimulation of Mouse Lymphocytes By a Mitogen Derived From Mycoplasma Arthritidis, 127 The Journal of Immunology 1931-1936 (1981).
Philippa Marrack and John Kappler, The Staphylococal Enterotoxins and Their Relatives, 248 Science 705-711 (1990).
Allen D. Sawitzke et al., Bacterial Superantigens in Disease, Virulence Mechanisms of Bacterial Pathogens 2nd ed. 145-169 (1995).
Andrew Herman et al., HLA-DR Alleles Differ in Their Ability to Present Staphylococcal Enterotoxins to T Cells, 172 J. Exp Med 709-717 (1990).
Paul R. Scholl et al., Staphylococcal Enterotoxin B and Toxic Shock Syndrome Toxin-1 Bind to Distinct Sites on HLA-DR and HLA-DQ Molecules, 143 The Journal of Immunology 2583-2588 (1989).
James M. Musser et al., A Single Clone of Staphylococcus Aureus Causes the Majority of Cases of Ttoxic Shock Syndrome, 87 Proc. Nat'l. Acad. Sci. USA 225-229 (1990).
Mark A. Tomai et al., Distinct T-Cell Receptor V.beta. Gene Usage by Human T Lymphocytes Stimulated with the Streptococcal Pyrogenic Exotoxins and pep M5 Protein, 60 Infection and Immunity 701-705 (1992).
Xiaowen He et al., Selective Induction of Rheumatoid Factors by Superantigens and Human Helper T Cells, 89 J. Clin. Invest. 673-680 (1992).
Mary K. Crow et al., Human B Cell Differentiation Induced By Microbial Superantigens: Unselected Peripheral Blood Lymphocytes Secrete Polyclonal Immunoglobulin Response to Mycoplasma Arthritidis Mitogen, 14 Autoimmunity 23-32 (1992).
Anne C. Avery et al., Activation of T Cells by Superantigen in Class II-Negative Mice, 153 The Journal of Immunology 4853-4861 (1994).
Barry C. Cole et al., Influence of Genes of the Major Histocompatibility Complex on Ulcerative Dermal Necrosis Induced in Mice by Mycoplasma arthritidis, 85 The Journal of Investigative Dermatology 357-361 (1985).
Barry C. Cole et al., Toxicity But Not Arthritogenicity of Mycoplasma arthritidis from Mice Associates with the Haplotype Expressed at the Major Histocompatibility Complex, 41 Infection and Immunity 1010-1015 (1983).
Roberto Baccala et al., Mycoplasma Arthritidis Mitogen V.beta. Engaged in Mice, Rats, and Humans, and Requirement of HLA-DRa for Presentation, 35 Arthritis and Rheumatism 434-441 (1992).
Barry C. Cole et al., Immunosuppressive Properties of the Mycoplasma arthritidis T-Cell Mitogen In Vivo: Inhibition of Proliferative Responses to T-Cell Mitogens, 58 Infection and Immunity 228-236 (1990).
Barry C. Cole and Marie M. Griffiths, Triggering and Exacerbation of Autoimmune Arthritis by the Mycoplasma Arthritidis Superantigen MAM, 36 Arthritis and Rheumatism 994-1002 (1993).
Curtis L. Atkin et al., the Mycoplasma arthritidis Superantigen MAM: Purification and Identification of an Active Peptide, 62 Infection and Immunity 5367-5374 (1994).
Barry C. Cole et al., Stimulation of Mouse Lymphocytes by a Mitogen Derived from Mycoplasma Arthritidis IV. Murine T Hybridoma Cells Exhibit Differential Accessory Cell Requirements for Activation by M. arthritidis T Cell Mitogen, Concanavalin A, or Hen Egg-white Lysozyme, 136 The Journal of Immunology 3572-3578,1986.
Curtis L. Atkin et al., Stimulation of Mouse Lymphcytes by a Mitogen Derived from Mycoplasma Arthritidis V. A Small Basic Protein from Culture Supernatants Is a Potent T Cell Mitogen, 137 The Journal of Immunology 1581-1589 (1986).
Steven M. Friedman et al., A Potential Role for Microbial Superantigens in the Pathogenesis of Systemic Autoimmune Disease, 34 Arthritis and Rheumatism 468-480 (1991).
Barry C. Cole et al., Genomic Composition and Allelic Polymorphisms Influence V.beta. Usage by the Mycoplasma Arthritidis Superantigen, 150 The Journal of Immunology 1-9 (1993).
Kotzin, BC et al, Adv. Immunol, vol. 54, p. 99-p.166, 1993.
Friedman, S.M et al. J. Exp. Med., vol. 174(4), pp. 891-900, 1991.
Cole, BC et al, J.of Exp. Med., vol. 183(3), pp. 1105-1110,1996.
Cole, BC, Current Topics in Microbiol. & Immun., pp. 107-119, vol. 174, 1991.
Swada, T et al, Infect. & Immun., vol. 63(9), pp. 3367-3372,1995.
Sambrook et , Molecular Cloning, Chapter 15 pp. 15.2-15.113, 1989.
Knudtson, KL et al, IOM Letters, vol. 3, Congress of Intl'l Org. Mycoplasmology, Jul. 19-26, 1994.
Atkin, CL et al, (Reg.), Infect. & Immun., vol. 62(1), pp. 5367-5375, 1994.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mycoplasma arthritidis superantigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mycoplasma arthritidis superantigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycoplasma arthritidis superantigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1115764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.